Literature DB >> 15583870

Acute effects of adrenergic agents on post-defibrillation arrest time in a cultured heart model.

V Krauthamer1, T C Smith.   

Abstract

Possible drug interactions with electrical defibrillation were examined. We tested the hypothesis that adrenergic agents (epinephrine, norepinephrine, isoproterenol) and a calcium channel blocker (verapamil), when applied acutely, alter the duration of arrest following a defibrillator shock. A secondary hypothesis (based on observations) was that the drugs alter the occurrence of changes to normal rhythms following the shock. Dissociated heart cells from 10-day chicken embryos were cultured to form spherical aggregates and plated in petri dishes. In the experiments, the spheres were paced at 0.75 V/cm above contraction threshold, and a biphasic defibrillator shock was applied for 1 ms at 46 V/cm. The arrest time and occurrence of rhythm changes were recorded. The adrenergic agents shortened the duration of arrest following a defibrillator shock, while the calcium channel blocker lengthened the arrest time. Comparisons with the control proportion of double beats showed no significant change with the adrenergic agents and a decrease with verapamil.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583870     DOI: 10.1007/s00018-004-4372-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  21 in total

Review 1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

2.  Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function.

Authors:  Yong-Mei Cha; Anita Wokhlu; Samuel J Asirvatham; Win-Kuang Shen; Paul A Friedman; Thomas M Munger; Jae K Oh; Kristi H Monahan; Janis M Haroldson; David O Hodge; Regina M Herges; Stephen C Hammill; Douglas L Packer
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-07-11

3.  A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

Authors:  Ross J Hunter; Thomas J Berriman; Ihab Diab; Ravindu Kamdar; Laura Richmond; Victoria Baker; Farai Goromonzi; Vinit Sawhney; Edward Duncan; Stephen P Page; Waqas Ullah; Beth Unsworth; Jamil Mayet; Mehul Dhinoja; Mark J Earley; Simon Sporton; Richard J Schilling
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-01

Review 4.  Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis.

Authors:  Saurav Chatterjee; Partha Sardar; Edgar Lichstein; Debabrata Mukherjee; Shamik Aikat
Journal:  Pacing Clin Electrophysiol       Date:  2012-09-14       Impact factor: 1.976

5.  Reversal of left ventricular dysfunction following ablation of atrial fibrillation.

Authors:  Philip J Gentlesk; William H Sauer; Edward P Gerstenfeld; David Lin; Sanjay Dixit; Erica Zado; David Callans; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-11-01

6.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

7.  A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

Authors:  R J Shelton; A L Clark; K Goode; A S Rigby; T Houghton; G C Kaye; J G F Cleland
Journal:  Heart       Date:  2009-03-11       Impact factor: 5.994

8.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

Authors:  Mohammed N Khan; Pierre Jaïs; Jennifer Cummings; Luigi Di Biase; Prashanthan Sanders; David O Martin; Josef Kautzner; Steven Hao; Sakis Themistoclakis; Raffaele Fanelli; Domenico Potenza; Raimondo Massaro; Oussama Wazni; Robert Schweikert; Walid Saliba; Paul Wang; Amin Al-Ahmad; Salwa Beheiry; Pietro Santarelli; Randall C Starling; Antonio Dello Russo; Gemma Pelargonio; Johannes Brachmann; Volker Schibgilla; Aldo Bonso; Michela Casella; Antonio Raviele; Michel Haïssaguerre; Andrea Natale
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

9.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

Authors:  David G Jones; Shouvik K Haldar; Wajid Hussain; Rakesh Sharma; Darrel P Francis; Shelley L Rahman-Haley; Theresa A McDonagh; S Richard Underwood; Vias Markides; Tom Wong
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

10.  Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).

Authors:  Ronald S Freudenberger; Alan C Wilson; John B Kostis
Journal:  Am J Cardiol       Date:  2007-06-04       Impact factor: 2.778

View more
  1 in total

1.  Acute effects of nonexcitatory electrical stimulation during systole in isolated cardiac myocytes and perfused heart.

Authors:  Ksenia Blinova; Jayna Stohlman; Victor Krauthamer; Alan Knapton; Eric Bloomquist; Richard A Gray
Journal:  Physiol Rep       Date:  2014-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.